OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 0.01%
Salicylic Acid 0.01%
Acne Treatment
For the treatment of Acne
Take an appropriate amount and spread evenly onto the skin.
For external use only
When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. avoid contact with eyes. If contact occurs, flush thoroughly with water.
People with allergy to aspirin will react poorly to the Salicylic Acid.
Keep out of reach of the children. If product is swallowed, get medical help or contact a poison control center right away.
Water, Butylene Glycol, Dipropylene Glycol, Glycerin, Niacinamide, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Polyglyceryl-4 Caprate, Carica Papaya (Papaya) Fruit Extract, Lens Esculenta (Lentil) Seed Extract, Hamamelis Virginiana (Witch Hazel) Extract, Nelumbo Nucifera Flower Extract, Swiftlet Nest Extract, Sodium Hyaluronate, Fructan, Allantoin, Adenosine, Hydroxyethyl Urea, Xylitol, Lactobionic Acid, Citric Acid, Sodium Citrate, 1,2-Hexanediol, Benzyl Glycol, Ethylhexylglycerin, Raspberry Ketone, Mentha Piperita (Peppermint) Oil
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 74472-003-02 | 2023-10-08 | C162847 | 48780-1 | 0191ceaa-713e-198a-e063-dbdaa90aec3e | 2023-10-09 De-listing 74472-003_SOME BY MI AHA BHA PHA 30 DAYS MIRACLE TONER |
| 74472-003-02 | 2023-07-28 | C162847 | 48780-1 | 0191ceaa-713e-198a-e063-dbdaa90aec3e | 2023-10-09 De-listing 74472-003_SOME BY MI AHA BHA PHA 30 DAYS MIRACLE TONER |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 74472-003 | 74472-003-01, 74472-003-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0736d961-8de3-5513-e063-6394a90ae10e | 6e27c88a-2a5f-4843-9e5e-057d84963a6b | 2023-10-08 | Warnings | 0736d961-8de3-5513-e063-6394a90ae10e 6e27c88a-2a5f-4843-9e5e-057d84963a6b |
Adverse event summaries are temporarily unavailable. Other product information remains available.